John Tayek, MD, MS, FACP, FACN
Investigator, LA BioMed
Research DescriptionDr. Tayek's research interests are in the area of normal and abnormal liver physiology, diabetes and clinical nutrition. He has been a Principal Investigator on an NIH study of patients with alcoholic hepatitis and cirrhosis (2005-8) and is currently a principal site Investigator on a NIH grant about alcoholic hepatitis). He has also done research in the field of diabetes mellitus and cardiovascular diseases. Dr. Tayek’s earlier NIH funded research also included development of equations to make accurate measurements of liver glucose and amino acid metabolism (NIH K08) in normal humans, diabetics and patients with systemic diseases.
Recent and/or Significant Publications
- Lopez, J. L., & Tayek, J. A. (2016). Voriconazole-Induced Hepatitis via Simvastatin-and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature. Drug Metabolism and Disposition, 44(1), 124-126.
- Patel, S. S., Molnar, M. Z., Tayek, J. A., Ix, J. H., Noori, N., Benner, D., ... & Kalantar-Zadeh, K. (2013). Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross‐sectional study and review of literature. Journal of cachexia, sarcopenia and muscle, 4(1), 19-29.
- Rattanasompattikul, M., Molnar, M. Z., Lee, M. L., Dukkipati, R., Bross, R., Jing, J., ... & MacDougall, I. C. (2013). Anti‐Inflammatory and Anti‐Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot‐feasibility, double‐blind, randomized, placebo‐controlled trial. Journal of cachexia, sarcopenia and muscle, 4(4), 247-257.
- Shah, A., Miller, C. J., Nast, C. C., Adams, M. D., Truitt, B., Tayek, J. A., ... & Clinkenbeard, E. L. (2014). Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. Nephrology Dialysis Transplantation, 29(12), 2235-2243.